Evolution of peritoneal dialysis in France since 2018 and during the «COVID years. RDPLF data report
DOI:
https://doi.org/10.25796/bdd.v5i3.67903Keywords:
Peritoneal dialysis, transfers, COVID-19, prevalence, incidence, home dialysis, transplantationAbstract
Almost all (99%) of the patients treated by peritoneal dialysis in France are registered in the RDPLF database. Apart from any statistical analysis aimed at interpreting the figures, this work is a report of the raw data observed in the population of Stage V renal failure patients treated by peritoneal dialysis since the beginning of the Covid epidemic and in the two years preceding it. Since the beginning of the epidemic, these data seem to show a decrease in the incidence of peritoneal dialysis treatment and an increase in transfers to center-based hemodialysis. In addition, there has been a decrease in the number of registrations on the transplant waiting list and a decrease in the number of transplants. While the temporary decrease in transplantation activity may be explained by the disorganization caused by the epidemic in the hospitals, a decrease in the number of indications for home dialysis probably merits further reflection on its causes, especially since this result is in contrast with trends in other countries. This report is intended to encourage more precise studies on the value of home dialysis during the epidemic.
References
- Situation de l’épidémie de COVID-19 chez les patients dialysés et greffés rénaux en France au 29 août 2022. BULLETIN N°106[Internet].
Available at https://www.agence-biomedecine.fr/IMG/pdf/bulletin_no106.pdf
- Cozzolino M, Conte F, Zappulo F, Ciceri P, Galassi A, Capelli I, Magnoni G, La Manna G. COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis? Clin Kidney J. 2021 Feb 2;14(Suppl 1):i6-i13. doi: 10.1093/ckj/sfab023. DOI: https://doi.org/10.1093/ckj/sfab023
- Rostoker G, Issad B, Fessi H, Massy ZA. Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective. J Nephrol. 2021 Aug;34(4):985-989. doi: 10.1007/s40620-021-01061-7. DOI: https://doi.org/10.1007/s40620-021-01061-7
- Canney M, Er L, Antonsen J, Copland M, Singh RS, Levin A. Maintaining the Uptake of Peritoneal Dialysis During the COVID-19 Pandemic: A Research Letter. Can J Kidney Health Dis. 2021 Feb 15;8:2054358120986265. doi: 10.1177/2054358120986265. DOI: https://doi.org/10.1177/2054358120986265
- Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022 Mar;42(2):110-153. DOI: https://doi.org/10.1177/08968608221080586
- Valentine Forté, Sophie Novelli, Mohamad Zaidan, Renaud Snanoudj, Christian Verger, Séverine Beaudreuil. Microbiology and outcomes of polymicrobial peritonitis associated with peritoneal dialysis: a register-based cohort study from the French Language Peritoneal Dialysis Registry (RDPLF). NDT (accepted september 2022)
- Verger C, Veniez G, Dratwa M. Variability of aseptic peritonitis rates in the RDPLF. Bull Dial Domic [Internet]. 2018 Jun. 13 [cited 2022 Sep. 5];1(1):9-13. Available from: https://doi.org/10.25796/bdd.v1i1.30 DOI: https://doi.org/10.25796/bdd.v1i1.30
- Lucas Pierre-michel J, Collart F, Baudoux T, Bonvoisin C, De Smet J-M, Devresse A, Mbaba Mena J, Radermacher L, des Grottes J-M. Has COVID-19 reduced the management of end-stage kidney disease in 2020? . Bull Dial Domic [Internet]. 2021 Apr. 7 [cited 2022 Sep. 5];4(1):53-4.
Available from: https://doi.org/10.25796/bdd.v4i1.61453 DOI: https://doi.org/10.25796/bdd.v4i1.61453
- Rivara MB, Mehrotra R. The changing landscape of home dialysis in the United States. Curr Opin Nephrol Hypertens. 2014 Nov;23(6):586-91. doi: 10.1097/MNH.0000000000000066. DOI: https://doi.org/10.1097/MNH.0000000000000066
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Christian Verger, Emmanuel Fabre
This work is licensed under a Creative Commons Attribution 4.0 International License.
